Iodine prophylaxis in pregnancy and lactation

Iodine supplementation at 200 µg daily for pregnant and lactating women to ensure adequate thyroid hormone supply for the foetus and newborn. WHO and Russian endocrinology guidelines support routine iodine supplementation in regions of mild-to-moderate iodine endemicity.

ICD-10 O99.21 drug

Also known as: Iodine supplementation in pregnancy

Drugs used for this condition

APotassium iodideFirst line · Iodine therapy for thyroid functionPotassium iodide 200 µg daily in pregnant and lactating women is first-line prevention of iodine deficiency, maternal hypothyroidism, and foetal neuropsychological developmental disorders. ATA 2017 gives a level A recommendation for routine iodine supplementation in populations with sub-adequate intake. Russian clinical guidelines support routine supplementation in the country's mild-to-moderate iodine endemicity.

How to read tiers A–F

Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.

AStrong evidence – first or second line in international guidelines
BRecommended in selected cases
CStudy data contradict each other
DBenefit not proven, no documented harm
FDocumented harm, or risk without benefit